Alis Biosciences says its goal is to return to investors billions of dollars stuck on the balance sheets of “moribund” ...

U.K. regulators cleared a multiple myeloma drug GSK withdrew from market three years ago. Elsewhere, an investment firm pressed Elevation Oncology to liquidate and the FDA relaxed risk monitoring ...

The president’s executive order promising to lower pharmaceutical prices includes support for a fix long sought by the ...

Commissioner Martin Makary said the agency would, whenever possible, restrict drug company employees from participating as ...

The drug, orforglipron, helped people with diabetes reduce their blood sugar levels while spurring significant weight loss, ...

The partners overcame an earlier rejection to win a seventh use for Dupixent, though some analysts are skeptical of its sales ...

Camzyos’ failure in a form of hypertrophic cardiomyopathy dampened its commercial outlook and spurred debate as to whether ...

HHS bypassed normal procedures as it laid off thousands of employees, according to sources. One union has already filed an ...

Novartis expects the new capacity will allow it to produce all of its key medicines “end to end” in the U.S., as the Trump ...

Signs of potential liver damage in a study participant led the company to abandon danuglipron, a drug it hoped would help it ...

Two studies published in Nature found stem cell-derived products can not only be safely transplanted into the brain, but also ...

The startup, affiliated with China-based antibody designer Helixon Therapeutics, is developing bispecific drugs aimed at ...